Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5379 Journals
4132 Congresses
9500+ Unique Records

Rare Tumors


Title Abbreviation
Rare Tumors
ISSN
2036-3605
Electronic ISSN
2036-3613
Readership
Cell Biologists, Hematologists, Immunologists, Oncologists, Physicians, Scientists
Scope
Rare Tumors is an open access, peer-reviewed international medical journal devoted entirely to the study, diagnosis, and treatment of rare cancers. The journal covers the diagnosis, classification, and treatment of rare tumors and hematological malignancies for physicians and medical scientists interested in uncommon neoplasms. The primary intent of the journal will be to publish clinically relevant information that will directly improve the care of patients with rare cancers. Basic science studies of interest to those treating rare malignancies will also be considered for publication when relevant. A special section of the journal is dedicated to Case Reports: we would like to invite clinicians and researchers to send us their reports.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
SAGE Publications - UK
To see more details about Rare Tumors, Subscribe Now!
Electronic Circulation Submission to Acceptance Rejection Rate Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library